Below is a list of BioTech Stocks with upcoming catalysts for a potential Run-Up play.
GET DATA FOR ALL THESE BIOTECH STOCKS AND MORE HERE AT OPTIONDATA.NET!!! SEE WHAT HAPPENED BEFORE, DURING, AND AFTER CRITICAL FDA DECISIONS, PDUFA, AND PHASE I, II, AND III TRIAL DATA
GET 25% OFF HISTORICAL OPTION DATA ORDER OF $200 OF MORE USING THE CODE: BooyahData!
Before Making Any More Trades, We Highly Recommend Signing Up For a FREE Personal Capital Account and Review/Compare Positions In All Your Trading Accounts CLICK HERE!
In Tony Pelz's The Biotech Traders Handbook, he points out a number of important variables to consider when investing in biotech stocks. This can help filter out the garbage and help you create a list of important solid stocks to focus on.Below is a description of what each column is showing:
Mean Recommendation (This Week)- Current mean recommendation from all analysts covering this stock. 1 is buy 5 is sell
Mean Recommendation (Last Week)- Last weeks mean recommendation from all analysts for comparison to this week
Net Shares Purchased (Sold)- Total shares purchased or sold by insiders over the past 6 months
Total Insider Shares Held- Current total of shares held by insiders
% Net Shares Purchased (Sold)- The % of the total shares bought or sold by insiders over the past 6 months
Shares Outstanding- Total shares outstanding for the individual stock Float- The total number of shares publicly owned and available for trading
% Held by Insiders- % of outstanding shares owned by insiders
% Held by Institutions- % of outstanding shares owned by institutions
Short % of Float- Current % of float that is being held short
Total Cash Per Share- The company's total cash divided by its shares outstanding Above is a sample of that data for stocks with important catalysts in the near future.